Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (BEIGF) Income from Non-Controlling Interests (2017 - 2020)

BeOne Medicines (BEIGF) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with $96000.0 as the latest value for Q4 2020.

  • Quarterly Income from Non-Controlling Interests fell 42.17% to $96000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $96000.0 through Sep 2021, up 102.71% year-over-year, with the annual reading at -$3.6 million for FY2020, 85.49% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2020 was $96000.0 at BeOne Medicines, up from -$1.4 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $1.5 million in Q4 2018, with the low at -$1.4 million in Q3 2020.
  • Average Income from Non-Controlling Interests over 4 years is -$401666.7, with a median of -$429000.0 recorded in 2019.
  • Peak annual rise in Income from Non-Controlling Interests hit 3493.02% in 2018, while the deepest fall reached 513.33% in 2018.
  • Over 4 years, Income from Non-Controlling Interests stood at $43000.0 in 2017, then skyrocketed by 3493.02% to $1.5 million in 2018, then tumbled by 89.26% to $166000.0 in 2019, then crashed by 42.17% to $96000.0 in 2020.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $96000.0, -$1.4 million, and -$1.1 million for Q4 2020, Q3 2020, and Q2 2020 respectively.